← Issue №18/ week of Nov 1, 2026/IBD

Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD retrospective · n=157,737 · Nov 1, 2026 · Inflamm Bowel Dis · IF 4.5

Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study.

New evidenceepidemiologybiologicsJAK inhibitorsanti-TNF
Clinical takeawayReassure IBD patients that RSV risk and outcomes are comparable to non-IBD patients, and continue current RSV vaccination recommendations.
What it foundRSV incidence was similar in IBD and non-IBD patients (219 vs 426 cases), with hospitalization rates of 18.26% vs 13.15% (P=0.08).
ContextConfirms prior evidence that IBD does not increase RSV risk or severity, even across medication classes.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Khan N … Farraye FA · Inflammatory Bowel Diseases · IF 4.5 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues